Antoni Vilaseca1,2, Daniel P Nguyen1, Emily A Vertosick3, Renato B Corradi1, Mireia Musquera2, Meritxell Pérez2, Nicola Fossati1, Daniel D Sjoberg3, Ramon Farré4, Isaac Almendros4, Josep M Montserrat5, Nicole E Benfante1, A Ari Hakimi1, Anders J Skanderup6, Paul Russo1,7, Antonio Alcaraz2, Karim A Touijer8,9. 1. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. 2. Urology Department, Hospital Clínic de Barcelona, Barcelona, Spain. 3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4. Unit of Biophysics and Bioengineering, Universitat de Barcelona, Barcelona, Spain. 5. Pneumology Department, Hospital Clínic de Barcelona, Barcelona, Spain. 6. Computational and Systems Biology, Genome Institute of Singapore, Singapore, Singapore. 7. Weill Cornell Medical College, New York, NY, USA. 8. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. touijera@mskcc.org. 9. Weill Cornell Medical College, New York, NY, USA. touijera@mskcc.org.
Abstract
PURPOSE: To assess the association between obstructive sleep apnea (OSA) and Fuhrman grade in patients with clear cell renal cell carcinoma (ccRCC). As secondary endpoints, we studied its association with tumor size, metastasis-free survival (MFS) and cancer-specific survival (CSS). METHODS: We reviewed the databases of two tertiary care centers, identifying 2579 patients who underwent partial or radical nephrectomy for ccRCC between 1991 and 2014. Descriptive statistics were used to compare pathologic variables between patients with and without OSA. Linear and logistic regression models were used to assess the association of OSA with Fuhrman grade and tumor size. A Cox proportional hazards model was used to determine OSA association with MFS and CSS. A pathway analysis was performed on a cohort with available gene expression data. RESULTS: In total, 172 patients (7 %) had self-reported OSA at diagnosis. More patients with OSA had high Fuhrman grade compared to those without OSA [51 vs. 38 %; 13 % risk difference; 95 % confidence interval (CI), 5-20 %; p = 0.003]. On multivariable analysis, the association remained significant (OR 1.41; 95 % CI 1.00-1.99; p = 0.048). OSA was not associated with tumor size (p > 0.5), MFS (p = 0.5) or CSS (p = 0.4). A trend toward vascular endothelial growth factor pathway enrichment was seen in OSA patients (p = 0.08). CONCLUSIONS: OSA is associated with high Fuhrman grade in patients undergoing surgery for ccRCC. Pending validation of this novel finding in further prospective studies, it could help shape future research to better understand etiological mechanisms associated.
PURPOSE: To assess the association between obstructive sleep apnea (OSA) and Fuhrman grade in patients with clear cell renal cell carcinoma (ccRCC). As secondary endpoints, we studied its association with tumor size, metastasis-free survival (MFS) and cancer-specific survival (CSS). METHODS: We reviewed the databases of two tertiary care centers, identifying 2579 patients who underwent partial or radical nephrectomy for ccRCC between 1991 and 2014. Descriptive statistics were used to compare pathologic variables between patients with and without OSA. Linear and logistic regression models were used to assess the association of OSA with Fuhrman grade and tumor size. A Cox proportional hazards model was used to determine OSA association with MFS and CSS. A pathway analysis was performed on a cohort with available gene expression data. RESULTS: In total, 172 patients (7 %) had self-reported OSA at diagnosis. More patients with OSA had high Fuhrman grade compared to those without OSA [51 vs. 38 %; 13 % risk difference; 95 % confidence interval (CI), 5-20 %; p = 0.003]. On multivariable analysis, the association remained significant (OR 1.41; 95 % CI 1.00-1.99; p = 0.048). OSA was not associated with tumor size (p > 0.5), MFS (p = 0.5) or CSS (p = 0.4). A trend toward vascular endothelial growth factor pathway enrichment was seen in OSA patients (p = 0.08). CONCLUSIONS: OSA is associated with high Fuhrman grade in patients undergoing surgery for ccRCC. Pending validation of this novel finding in further prospective studies, it could help shape future research to better understand etiological mechanisms associated.
Authors: Ganesh V Raj; R Houston Thompson; Bradley C Leibovich; Michael L Blute; Paul Russo; Michael W Kattan Journal: J Urol Date: 2008-04-18 Impact factor: 7.450
Authors: Isaac Almendros; Josep M Montserrat; Marta Torres; Maria R Bonsignore; Laura Chimenti; Daniel Navajas; Ramon Farré Journal: Sleep Med Date: 2012-11-11 Impact factor: 3.492
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Francisco Campos-Rodriguez; Miguel A Martinez-Garcia; Montserrat Martinez; Joaquin Duran-Cantolla; Monica de la Peña; María J Masdeu; Monica Gonzalez; Felix del Campo; Inmaculada Gallego; Jose M Marin; Ferran Barbe; Jose M Montserrat; Ramon Farre Journal: Am J Respir Crit Care Med Date: 2012-11-15 Impact factor: 21.405
Authors: Isaac Almendros; Yang Wang; Lev Becker; Frances E Lennon; Jiamao Zheng; Brittney R Coats; Kelly S Schoenfelt; Alba Carreras; Fahed Hakim; Shelley X Zhang; Ramon Farré; David Gozal Journal: Am J Respir Crit Care Med Date: 2014-03-01 Impact factor: 21.405
Authors: A Ari Hakimi; Helena Furberg; Emily C Zabor; Anders Jacobsen; Nikolaus Schultz; Giovanni Ciriello; Nina Mikklineni; Brandon Fiegoli; Philip H Kim; Martin H Voss; Hui Shen; Peter W Laird; Chris Sander; Victor E Reuter; Robert J Motzer; James J Hsieh; Paul Russo Journal: J Natl Cancer Inst Date: 2013-11-27 Impact factor: 13.506
Authors: Antoni Vilaseca; Noelia Campillo; Marta Torres; Mireia Musquera; David Gozal; Josep M Montserrat; Antonio Alcaraz; Karim A Touijer; Ramon Farré; Isaac Almendros Journal: PLoS One Date: 2017-06-08 Impact factor: 3.240
Authors: David Gozal; Isaac Almendros; Amanda I Phipps; Francisco Campos-Rodriguez; Miguel A Martínez-García; Ramon Farré Journal: Int J Mol Sci Date: 2020-11-20 Impact factor: 5.923
Authors: Isaac Almendros; Miguel Ángel Martínez-García; Francisco Campos-Rodríguez; Erica Riveiro-Falkenbach; José L Rodríguez-Peralto; Eduardo Nagore; Antonio Martorell-Calatayud; Luis Hernández Blasco; Jose Bañuls Roca; Eusebi Chiner Vives; Alicia Sánchez-de-la-Torre; Jorge Abad-Capa; Josep Maria Montserrat; Amalia Pérez-Gil; Valentín Cabriada-Nuño; Irene Cano-Pumarega; Jaime Corral-Peñafiel; Trinidad Diaz-Cambriles; Olga Mediano; Joan Dalmau-Arias; Ramon Farré; David Gozal Journal: Front Neurol Date: 2018-04-26 Impact factor: 4.003